for subscribers

Ascendis Health gets ball rolling in Europe

Share your Subscriber Article
You have 5 articles to share every month. Send this story to a friend!

Johannesburg – Ascendis Health [JSE:ASC] has finalised a number of European acquisitions in recent months which are expected to boost profit margins in 2018.

This is according to a statement issued by the JSE-listed pharmaceutical company on Monday. The company unpacked its two new European acquisitions.

Recently Ascendis Health had concluded its acquisition of Cipla Agrimed SA and Cipla Vet SA for R375m. This acquisition officially became unconditional on June 1 and is expected to help Ascendis expand into the veterinary pharma market and assist the company’s international strategy through expansions into new African markets.

There’s more to this story
Subscribe to News24 and get access to our exclusive journalism and features today.
Subscribe
Already a subscriber? Sign in
ZAR/USD
17.66
(-0.06)
ZAR/GBP
23.09
(+0.20)
ZAR/EUR
20.74
(+0.16)
ZAR/AUD
12.67
(-0.06)
ZAR/JPY
0.17
(+0.37)
Gold
2004.20
(-1.19)
Silver
28.07
(-3.42)
Platinum
972.00
(-1.27)
Brent Crude
44.95
(+1.33)
Palladium
2218.00
(-0.00)
All Share
57060.27
(+0.53)
Top 40
52709.89
(+0.52)
Financial 15
10071.67
(+1.76)
Industrial 25
74571.58
(-0.13)
Resource 10
59518.29
(+0.97)
All JSE data delayed by at least 15 minutes morningstar logo
Company Snapshot
Voting Booth
Do you think it was a good idea for the government to approach the IMF for a $4.3 billion loan to fight Covid-19?
Please select an option Oops! Something went wrong, please try again later.
Results
Yes. We need the money.
11% - 945 votes
It depends on how the funds are used.
74% - 6301 votes
No. We should have gotten the loan elsewhere.
15% - 1298 votes
Vote